Compound Summary
Compound Information
olomoucine
Compound Name: | olomoucine |
Compound CID: | 4592 |
Synonyms: | olomoucine 101622-51-9 Olomucine 4erk UNII-6A839B2HYS More... |
Iupac Name: | 2-[[6-(benzylamino)-9-methylpurin-2-yl]amino]ethanol |
InChI: | InChI=1S/C15H18N6O/c1-21-10-18-12-13(17-9-11-5-3-2-4-6-11)19-15(16-7-8-22)20-14(12)21/h2-6,10,22H,7-9H2,1H3,(H2,16,17,19,20) |
InChIKey: | GTVPOLSIJWJJNY-UHFFFAOYSA-N |
Canonical Smiles: | CN1C=NC2=C(N=C(N=C21)NCCO)NCC3=CC=CC=C3 |
Isomeric Smiles: | CN1C=NC2=C(N=C(N=C21)NCCO)NCC3=CC=CC=C3 |
Molecular Weight: | 298.34 |
Molecular Formula: | C15H18N6O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
olomoucine
Molecular Weight: | 298.34 |
Molecular Formula: | C15H18N6O |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 22 |
Complexity: | 338 |
Synonyms
olomoucine
| olomoucine | olomoucine |
|---|---|
olomoucine |
101622-51-9 |
Olomucine |
4erk |
UNII-6A839B2HYS |
6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine |
2-(2-Hydroxyethylamino)-6-benzylamino-9-methylpurine |
2-((6-(Benzylamino)-9-methyl-9H-purin-2-yl)amino)ethanol |
2-{6-(benzylamino)-9-methyl-9h-purin-2-ylamino}ethanol |
MFCD00189360 |
NSC-666096 |
2-(2-Hydroxyethylamino)-6-(benzylamino)-9-methylpurine |
6A839B2HYS |
CHEMBL280074 |
2-(Hydroxyethylamino)-6-benzylamino-9-methylpurine |
6-Benzylamino-2-(2-hydroxyethylamino)-9-methylpurine |
2-6-(benzylamino)-9-methylpurin-2-ylaminoethanol |
2-{6-(benzylamino)-9-methyl-9H-purin-2-ylamino}ethan-1-ol |
Ethanol, 2-9-methyl-6-(phenylmethyl)amino-9H-purin-2-ylamino- |
Ethanol,2-9-methyl-6-(phenylmethyl)amino-9H-purin-2-ylamino- |
OLO |
6-Benylamino-2-(2-hydroxyethylamino)-9-methylpurine |
6-benzylamino-2-2-hydroxyethylamino-9-methylpurine |
2-(2-Hydroxyethylamino)-6-benzylamino-9-isopropylpurine |
C15H18N6O |
2-9-Methyl-6-(phenylmethyl)amino-9H-purin-2-ylamino-ethanol |
ethanol, 2-((9-methyl-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)- |
SR-01000075518 |
InSolution™ Olomoucine |
2-((6-(benzylamino)-9-methyl-9H-purin-2-yl)amino)ethan-1-ol |
purine deriv. 5 |
NSC 666096 |
Kinome_2870 |
Tocris-1284 |
1w0x |
ACMC-20cp0o |
BiomolKI_000046 |
Lopac-O-0886 |
BiomolKI2_000052 |
UPCMLD-DP136 |
CBiol_002050 |
Lopac0_000883 |
BSPBio_000990 |
KBioGR_000330 |
KBioSS_000330 |
SCHEMBL135056 |
BDBM5718 |
BMK1-E10 |
Olomoucine, >=98% (HPLC) |
UPCMLD-DP136:001 |
UPCMLD-DP136:002 |
BCBcMAP01_000205 |
CHEBI:44661 |
KBio2_000330 |
KBio2_002898 |
KBio2_005466 |
KBio3_000659 |
KBio3_000660 |
DTXSID90144068 |
Bio1_000336 |
Bio1_000825 |
Bio1_001314 |
Bio2_000335 |
Bio2_000815 |
HMS1362B11 |
HMS1792B11 |
HMS1990B11 |
HMS3262B08 |
HMS3267L09 |
HMS3403B11 |
HMS3412E10 |
HMS3650F19 |
HMS3676E10 |
ZINC1641925 |
Tox21_500883 |
1966AH |
NSC666096 |
AKOS005145988 |
CCG-100650 |
CS-W012144 |
DB02116 |
LP00883 |
SDCCGSBI-0050858.P002 |
IDI1_002090 |
Olomoucine - CAS 101622-51-9 |
SMP1_000281 |
2,6,9-Trisubstituted purine deriv. 26 |
NCGC00015763-01 |
NCGC00015763-02 |
NCGC00015763-03 |
NCGC00015763-04 |
NCGC00015763-05 |
NCGC00015763-06 |
NCGC00015763-07 |
NCGC00015763-08 |
NCGC00015763-09 |
NCGC00025096-01 |
NCGC00025096-02 |
NCGC00025096-03 |
NCGC00025096-04 |
NCGC00025096-05 |
NCGC00025096-06 |
NCGC00025096-07 |
NCGC00261568-01 |
NCI60_022916 |
EU-0100883 |
FT-0642456 |
ST50298830 |
O 0886 |
A934871 |
J-000453 |
SR-01000075518-1 |
SR-01000075518-3 |
SR-01000075518-6 |
BRD-K82731415-001-03-9 |
BRD-K82731415-001-04-7 |
Q27093184 |
2-6-(benzylamino)-9-methyl-purin-2-ylaminoethanol |
2-({9-methyl-6-benzylaminopurin-2-yl}amino)ethan-1-ol |
2-(6-(benzylamino)-9-methyl-9H-purin-2-ylamino)ethanol |
6-(benzylamino)-2-(2-hydroxyethyl)amino-9-methylpurine |
2-9-methyl-6-(phenylmethylamino)purin-2-ylaminoethanol |
2-9-Methyl-6-(phenylmethyl)amino-9H-purin-2-ylaminoethanol |
2-9-Methyl-6-(phenylmethyl)amino-9H-purin-2-ylaminoethanol, 9CI |
Experimental Data
olomoucine
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 5 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
olomoucine
Statistics Data
olomoucine
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 5 | 1 | 1 |
Statistics Data Visualization
olomoucine
